15 min ago
A Bull/Bear Outline For The Unilife Debate
In our previous article on Unilife , published on November 27th 2013, we predicted that UNIS would probably break 100% in YTD gains.
4 hrs ago
Novartis Africa Day Highlights Company's Efforts to Expand Access to Healthcare
"Novartis is taking an outcomes approach, looking beyond therapeutic solutions to a focus on new technologies, new commercial models, education and training," says Joseph Jimenez, Chief Executive Officer of Novartis, who will open the event.
Wed Dec 04, 2013
Unilife: A Look At The Novartis News
On Monday night, after markets were closed, Unilife Corp announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs.
Stocks to Watch: Unilife Corp
Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Tue Dec 03, 2013
Supply Deal Leads Unilife Corp (UNIS) to New High
Under the deal's terms, UNIS will provide a customized delivery device for one of NVS' early stage pipeline drugs.
RDInvesting Provides Investors with Free In-Depth Equity Reports on...
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events.
Mon Dec 02, 2013
Glivec Generics May Be Delayed In The U.S. - Buy Novartis
Glivec which is prescribed for the treatment of Ph+ chronic myeloid leukemia is one of the most profitable drug in Novartis marketed drug portfolio.
Sun Dec 01, 2013
Buy Novartis For A Safe And Growing Income
Novartis is a Swiss multinational pharmaceutical company, ranking among the largest companies among the worldwide industry by sales.
Fri Nov 29, 2013
Novus Energy Inc. announces third quarter 2013 results
These may be accessed through the SEDAR website www.sedar.com under the Company's profile and at the Company's website www.novusenergy.ca .
Thu Nov 28, 2013
Novartis Foundation launches new leprosy strategy at symposium on disease elimination
Novartis International AG /Novartis Foundation launches new leprosy strategy at symposium on disease elimination .
Sun Nov 24, 2013
Swiss Voters Reject Strict CEO Pay Limits in Referendum
Swiss voters rejected a proposal to limit executives' pay to 12 times that of junior employees, a measure that would have gone further than any other developed nation.
Sat Nov 23, 2013
United States : NOVARTIS to return $5 billion to shareholders via 2-year share repurchase PROGRAM
Novartis has pledged to return $5 billion to shareholders through a two-year share repurchase program, which is a branch of its strategy to "strengthen portfolio and capital allocation."
Fri Nov 22, 2013
Novartis ambushes Pfizer with breast cancer treatment
"How Novartis kept LEE011's development under wraps and snuck up on PFE is unclear," writes FierceBiotech 's Damian Garde, referencing news that NVS is moving LEE011 into Phase 3 testing next month.
Wall Street Breakfast: Must-Know News
Top Stories South Korea to acquire 40 F-35 combat jets. South Korea intends to buy 40 Lockheed Martin F-35 fighter planes in an 8.3T won deal, with the government opting for aircraft that are more expensive but have greater stealth capabilities as it looks to defend the country against North Korea's nuclear threat.
Novartis Announces $5B Share Buyback
Novartis today announced the launch of a USD 5 billion share buyback, reflecting the company's confidence in its long-term growth prospects, as well as its commitment to deliver strong shareholder returns.
The Washington Post
Novartis to Buy Back $5 Billion in Stock, Add Business Segments
Novartis AG plans to buy back $5 billion of stock over two years and said it will expand in areas such as treatments for skin and heart diseases.
Thu Nov 21, 2013
Novartis sweetens investors with $5 billion share buyback
Swiss drugmaker Novartis offered a sweetener to investors on Friday by starting a $5 billion share buyback programme, but shied away from announcing any radical surgery to its structure.
Swiss vote may cap CEO pay at 12X lowest worker's salary
Swiss voters will weigh in on a referendum Sunday that would pass legislation to cap the pay of top executives at no more than 12 times the lowest-paid workers in their companies.
Tue Nov 19, 2013
The Daily Princetonian
Vaccine manufacturer Novartis likely not to benefit from emergency deal with Princeton
The commercial success of Bexsero - the vaccine made by Swiss pharmaceutical company Novartis that will be offered to Princeton students in December and is not yet licensed for use in the United States - is crucial for the future of the company's vaccine department, according to a review of financial disclosure forms.
Sun Nov 17, 2013
Supernus Pharma: Solid Results Demonstrate Solid Execution; Maintaining Positive Outlook
We continue to maintain our positive outlook on Supernus Pharmaceuticals Inc. shares as the company continues to report impressive results and has had an excellent year so far, with the launch of two products for treatment of epilepsy.